Name:	aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod
Namespace Prefix:	aciu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Collaborative agreement, potential receivables for option exercise fee and potential development, commercial and sales-based milestones

No definition available.

Name:	aciu_CollaborativeAgreementPotentialReceivablesForOptionExerciseFeeAndPotentialDevelopmentCommercialAndSalesBasedMilestones
Namespace Prefix:	aciu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Collaborative agreement, upfront payments received

No definition available.

Name:	aciu_CollaborativeAgreementUpfrontPaymentsReceived
Namespace Prefix:	aciu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Number of development milestones that may occur prior to option exercise included in transaction price

No definition available.

Name:	aciu_NumberOfDevelopmentMilestonesThatMayOccurPriorToOptionExerciseIncludedInTransactionPrice
Namespace Prefix:	aciu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

The number of performance obligations identified applicable to the entity's assessment of a specific contractual arrangement.

No definition available.

Name:	aciu_NumberOfPerformanceObligationsIdentified
Namespace Prefix:	aciu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

The amount of an entity’s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_105&doctype=Standard
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Paragraph 116
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_116_a&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_ContractLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

No definition available.

Name:	ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_114&doctype=Standard
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Paragraph 120
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_a&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Name:	ifrs-full_TypesOfContractsAxis=aciu_AntiAbetaActiveImmunotherapyInAd2024AgreementTakedaPharmaceuticalsUsaInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_PerformanceObligationsAxis=aciu_LicenseOptionAndDevelopmentCmcAndRegulatoryActivitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_PerformanceObligationsAxis=aciu_LicenseOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ifrs-full_PerformanceObligationsAxis=aciu_DevelopmentCmcAndRegulatoryActivitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: